Trump administration will allow pharmacies to make popular peptides

Source: https://www.npr.org/2026/10/28/nx-s1-6021030/peptides-compounding-enforcement

Accessibility links

- Skip to main content

- Keyboard shortcuts for audio player

!Image 2Audio 2

****Play Live Radio****

- **Hourly News**

- **Listen Live**

- **My Playlist**

- Open Navigation Menu

- 

- Newsletters

- Sign InPersonalize Your Experience

- NPR Shop

- Get NPR+

* Donate

- Local Station

- NPR Network

Close Navigation Menu

- Home

- NewsExpand/collapse submenu for News

- National

- World

- Politics

- Business

- Elections

- Health

- Science

- Climate

- Race

- CultureExpand/collapse submenu for Culture

- Books

- Movies

- Television

- Pop Culture

- Food

- Art & Design

- Performing Arts

- Life Kit

- Gaming

- MusicExpand/collapse submenu for Music

- Tiny Desk

- New Music Friday

- All Songs Considered

- Music Features

- Live Sessions

- Podcasts & ShowsExpand/collapse submenu for Podcasts & Shows

Daily

- 

- 

- 

- 

- 

- 

- 

Featured

- 

- 

- 

- 

- 

- 

- More Podcasts & Shows

- Search

- Newsletters

- NPR Shop

- Get NPR+

- Sign InPersonalize Your Experience

- [](https://www.npr.org/music/)

- Tiny Desk

- New Music Friday

- All Songs Considered

- Music Features

- Live Sessions

- About NPR

- Diversity

- Support

- Careers

- Press

- Ethics

**Small compounding pharmacies won't be penalized for making peptides****The Department of Health and Human Services will let small compounding pharmacies make six peptides that haven't been approved by the Food and Drug Administration. It may not be enough to meet demand.**

[](https://www.npr.org/2026/10/28/nx-s1-6021030/peptides-compounding-enforcement)

Treatments and Tests

Trump administration will allow pharmacies to make popular peptides

October 28, 2026 6:26 PM ET

By

Sydney Lupkin


Secretary of Health and Human Services Robert F. Kennedy Jr. has supported broader access to peptides. A new policy will make it easier for small compounding pharmacies to make them. **Heather Diehl/Getty Images******hide caption****

**toggle caption**i

Heather Diehl/Getty Images

Unproven but popular peptides touted for wellness have been available on the gray market, despite an official ban. Now, the Department of Health and Human Services is looking to bring them out of the shadows.


Short Wave

MAHA's midterm report card

HHS said in a new policy that it will exercise enforcement discretion for a half dozen peptides, essentially looking the other way when they're made by small compounding pharmacies.

Health Secretary Robert F. Kennedy Jr. has been a vocal supporter of peptides, saying he has used some of them himself.

Peptides are strings of amino acids, shorter than proteins, that can exert powerful effects in the body. Some occur naturally and others are synthetic variations. Wellness influencers and some clinicians have promoted unproven peptides for a wide range of uses, though the evidence for their safety and effectiveness is sparse.

Sponsor Message

So even though these peptides have not been through the Food and Drug Administration's rigorous drug review and approval process, they could become easier to get. But the policy's focus on smaller producers may mean that pharmacists will have a tough time meeting demand.

In July, a panel of advisers to the FDA voted in favor of expanded access to six peptides through compounding pharmacies. However, at the same meeting the FDA's own scientists recommended against unwinding the existing restrictions on them.

The new policy says compounding is a safer alternative to illicit "research-use-only" peptides that are available online. They're often sourced from sketchy suppliers overseas.

The peptides, and some of their unproven uses, are:

- BPC-157, ulcerative colitis

- Epitalon, insomnia

- KPV, wound healing

- MOTS-c, metabolic health

- Semax, migraine

- TB-500, wound healing

Joshua Fritzler, the president of Olympia and Wesley Pharmaceuticals in central Florida, says people have been asking about these peptides for years. But because they were illegal to compound, his company didn't make them.

The new policy doesn't change their legal status, but it does create a path for small compounders, called 503A compounding pharmacies. It doesn't apply to the larger ones, called 503Bs, that are outsourcing facilities producing higher volumes of medicines.

Sponsor Message

So at Fritzler's company, only its smaller compounding facility will be able to make the peptides – and only in small quantities, he says.

And that has implications for consumers.

"We won't be able to meet demand," he says, explaining that Olympia will likely only compound one of the six peptides and needs to get its facility ready first. "I don't think all the [503]As in the country could meet the demand."

The Alliance for Pharmacy Compounding's CEO Scott Brunner wrote in a statement that his group is pleased with the administration's decision to allow the peptides to be compounded because it offers a "more accountable alternative" for patients seeking gray market peptides.

[](https://www.npr.org/2026/07/23/nx-s1-5903202/fda-peptides-restrictions)

Health

FDA panel supports broadening access to peptides popular on the gray market

"It also brings patients into a system where pharmacy standards, regulatory oversight, and serious adverse event reporting apply," he says.

Brunner warned, however, that it may take some time for compounding pharmacies to begin dispensing these products to patients. That's because ingredient suppliers need to make sure their active ingredients meet the policy's requirements — and pharmacies need to verify that, too.

Several consumer advocacy groups say the policy puts patients at risk, however. The nonprofit Public Citizen noted that Kennedy seems to have acted unilaterally rather than through the typical rulemaking process.

"By allowing unproven and potentially unsafe peptides to be manufactured, marketed and prescribed without concern about potential federal enforcement actions, Kennedy has undermined the FDA and threatened public health," Dr. Robert Steinbrook, Health Research Group Director at Public Citizen wrote in a statement. "All peptide substances should go through the standard FDA approval process for new drugs. The HHS Secretary should support, not sabotage, needed FDA enforcement actions to protect consumers."

Steinbrook advised clinicians to talk to their patients and tell them about the risk of contamination and other adverse effects.

The Partnership for Safe Medicines, which includes various pharmacy and pharmacist organizations around the country, filed a citizen petition last week, urging the FDA to ignore the recommendation from its advisory committee in July to allow compounding pharmacies to make the six peptides.

Sponsor Message

"Today's decision leaves Americans in a grey area as to whether peptides are safe or not, even though the FDA's own scientists recommended against voting in favor of these substances due to concerns with evidence," its executive director Shabbir Safda wrote in a statement.

**NPR does not offer or accept money for coverage or interviews.** Anyone who makes such an offer or request is not an NPR employee and does not represent NPR.

- peptides

- FDA

- HHS

- compounding pharmacies

- **Facebook**

- **Flipboard**

- **Email**

More Stories From NPR


##### Climate

#### [Forecasters are predicting a warmer and wetter winter. Here's how El Niño will affect your region](https://www.npr.org/2026/10/28/nx-s1-6009547/el-nino-forecast-us-winter "Forecasters are predicting a warmer and wetter winter. Here's how El Niño will affect your region")

[](https://www.npr.org/2026/10/28/nx-s1-6021478/doj-california-ballots-denied "Judge denies the Justice Department's bid to stop processing California ballots")

##### Voting

#### [Judge denies the Justice Department's bid to stop processing California ballots](https://www.npr.org/2026/10/28/nx-s1-6021478/doj-california-ballots-denied "Judge denies the Justice Department's bid to stop processing California ballots")

[](https://www.npr.org/2026/10/28/nx-s1-6021497/dhs-hack-ice "Hackers expose the identities of more than 40,000 DHS employees")

##### Immigration

#### [Hackers expose the identities of more than 40,000 DHS employees](https://www.npr.org/2026/10/28/nx-s1-6021497/dhs-hack-ice "Hackers expose the identities of more than 40,000 DHS employees")


##### Elections

#### [These are the House races to watch in the 2026 midterm election on Nov. 3](https://www.npr.org/2026/10/29/nx-s1-6020921/2026-house-map-democrats-flip-republicans-tossup-triage "These are the House races to watch in the 2026 midterm election on Nov. 3")


#### [Their colleges closed, but the government refuses to erase their debts, lawsuit says](https://www.npr.org/2026/10/29/nx-s1-6003916/student-loans-closed-colleges-education-department-trump-biden "Their colleges closed, but the government refuses to erase their debts, lawsuit says")


##### Obituaries

#### [Editor Rose Friedman, who helped shape NPR's cultural coverage, dies at 38](https://www.npr.org/2026/09/18/nx-s1-5973098/rose-friedman-dies "Editor Rose Friedman, who helped shape NPR's cultural coverage, dies at 38")

More Stories From NPR


##### Only on NPR

#### Are you an organ donor? Here are some rule changes you may want to know

[](https://www.npr.org/2026/09/29/nx-s1-5950439/embryo-gene-editing-babies-biotech)

##### Only on NPR

#### This startup wants to prove gene-editing embryos is safe for making healthy babies


##### Health

#### Medical groups offer vaccine guidance to fill federal vacuum


##### Health

#### Drugstores say Medicare's $50 obesity drug program is catching on

[](https://www.npr.org/2026/05/04/g-s1-119947/telehealth-abortion-mifepristone-misoprostol)

##### Treatments

#### Here's how medication abortion works with just one drug

[](https://www.npr.org/2026/04/25/nx-s1-5763797/planned-parenthood-botox-medcaid-trump-congress)

##### Only on NPR

#### Trump and Congress cut funding for Planned Parenthood. Can Botox keep it afloat?

Sponsor Message

Popular on NPR.org

[](https://www.npr.org/2026/10/29/1230906945/patrick-stewart-dead)

##### Obituaries

#### Patrick Stewart, a perceptive patriarch in 'Star Trek' and 'X-Men,' dies at 86


##### Your Turn with Allison Aubrey

#### Lost your spark? The "silent sister" of depression, and a quiz to spot her


##### Climate

#### Forecasters are predicting a warmer and wetter winter. Here's how El Niño will affect your region


##### Elections

#### These are the House races to watch in the 2026 midterm election on Nov. 3

[](https://www.npr.org/2026/10/29/nx-s1-6020451/avian-flu-penguins-pathogen-antarctica-cholera)

##### Global Health

#### What killed 500-plus penguins? How scientists solved the mystery

[](https://www.npr.org/2026/10/29/nx-s1-6012724/arizonas-lifeline-to-the-colorado-river-is-drying-up-its-designers-warned-us-decades-ago)

##### News

#### Arizona's lifeline to the Colorado River is drying up. Its designers warned us decades ago

NPR Editors' Picks

[](https://www.npr.org/2026/10/29/nx-s1-6022069/alaskas-all-important-senate-race-is-roiled-by-report-on-alleged-spoiler-candidate)

##### Statewide Races

#### Alaska's all-important Senate race is roiled by a report on alleged spoiler candidate


##### Sources & Methods

#### Israel deadlocked / Trump, Iran and the midterms

[](https://www.mainepublic.org/politics/2026-10-29/in-maines-senate-race-voters-weigh-opposing-views-of-susan-collins-power-and-influence?utm_source=npr.org&utm_medium=referral&utm_campaign=network_highlights)

##### [](https://www.npr.org/2026/10/28/nx-s1-6021030/peptides-compounding-enforcement)

#### In Maine's Senate race, voters weigh opposing views of Susan Collins' power and influence

[](https://www.npr.org/2026/10/29/nx-s1-6019228/manx-shearwater-jet-lag-birds)

##### Animals

#### Even birds get jet lagged, study shows

[](https://www.npr.org/2026/10/29/g-s1-150666/us-and-japan-agree-to-establish-a-japanese-facility-for-joint-missile-production)

##### World, reordering

#### US and Japan agree to establish a Japanese facility for joint missile production


##### Far-Flung Postcards

#### Greetings from Baghdad, where Agatha Christie's old home presents its own mystery

###### Read & Listen

- Home

- News

- Culture

- Music

- Podcasts & Shows

###### Connect

- Newsletters

- Facebook

- Instagram

- Press

- Public Editor

- Corrections

- Transcripts

- Contact & Help

###### About NPR

- Overview

- Diversity

- NPR Network

- Accessibility

- Ethics

- Finances

###### Get Involved

- Support Public Radio

- Sponsor NPR

- NPR Careers

- NPR Shop

- NPR Extra

- Terms of Use

- Privacy

- Your Privacy Choices

- Text Only

- © 2026 npr

Sponsor Message

Sponsor Message

Become an NPR sponsor

!Image 44: NPR Plus logo ##### Exclusive benefits

###### Give a little. Get a lot.

Support mission-driven journalism while getting something great in return. Enjoy bonus content, early access and sponsor-free listening from your favorite NPR podcasts.

Get NPR+

Already have NPR+?Sign In

Close modal

!Image 45: NPR logo

Cookie Settings

When you visit our website or app, we store cookies on your browser, use similar tracking and storage technologies such as software development kits, and use information about the device you use to access our site or app (together "cookies"). The information these cookies collect might relate to you, your preferences or your device, and is mostly used to make the site or app work as you expect them to and to provide a more personalized web or app experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site, app, and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You may opt out of the sharing of your information with our sponsorship vendors for delivery of personalized sponsorship credits and marketing messages on our website or third-party sites by turning off "Share Data for Targeted Sponsorship" below. If you opt out, our service providers or vendors may continue to serve you non-personalized, non-"interest-based" sponsorship credits and marketing messages on our website or app or third-party sites or apps, and those sponsorship credits and marketing message may come with cookies that are used to control how often you encounter those credits and messages, to prevent fraud, and to do aggregate reporting. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website or app (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All

Manage Consent Preferences

#### Strictly Necessary or Essential Cookies

Always Active

These cookies are essential to provide you with services available through the NPR Services and to enable you to use some of their features. For example, these cookies allow NPR to remember your registration information while you are logged in. Local station customization, the NPR Shop, and other interactive features also use cookies. Without these cookies, the services that you have asked for cannot be provided, and we only use these cookies to provide you with those services.

#### Share Data for Targeted Sponsorship

- [x] Share Data for Targeted Sponsorship

You may opt out of the sharing of your information with our sponsorship vendors for delivery of personalized sponsorship credits and marketing messages on our website or third-party sites by turning off "Share Data for Targeted Sponsorship." If you opt out, our service providers or vendors may continue to serve you non-personalized, non-"interest-based" sponsorship credits and marketing messages on our website or third-party sites, and those sponsorship credits and marketing message may come with cookies that are used to control how often you encounter those credits and messages, to prevent fraud, and to do aggregate reporting.

- ##### Performance and Analytics Cookies

- [x] Switch Label

These cookies are used to collect information about traffic to our Services and how users interact with the NPR Services. The information collected includes the number of visitors to the NPR Services, the websites that referred visitors to the NPR Services, the pages that they visited on the NPR Services, what time of day they visited the NPR Services, whether they have visited the NPR Services before, and other similar information. We use this information to help operate the NPR Services more efficiently, to gather broad demographic information and to monitor the level of activity on the NPR Services.

- ##### Functional Cookies

- [x] Switch Label

These cookies allow our Services to remember choices you make when you use them, such as remembering your Member station preferences and remembering your account details. The purpose of these cookies is to provide you with a more personal experience and to prevent you from having to re-enter your preferences every time you visit the NPR Services.

- ##### Targeting and Sponsor Cookies

- [x] Switch Label

These cookies track your browsing habits or other information, such as location, to enable us to show sponsorship credits which are more likely to be of interest to you. These cookies use information about your browsing history to group you with other users who have similar interests. Based on that information, and with our permission, we and our sponsors can place cookies to enable us or our sponsors to show sponsorship credits and other messages that we think will be relevant to your interests while you are using third-party services.

Cookie List

Clear

- - [x] checkbox label label

Apply Cancel

Consent Leg.Interest

- [x] checkbox label label

- [x] checkbox label label

- [x] checkbox label label

Confirm My Choices